Petco Reports Fourth Quarter and Full Year 2025 Results
Rhea-AI Summary
Petco (Nasdaq: WOOF) reported Q4 and full-year 2025 results on March 11, 2026, delivering profitability ahead of outlook and reducing leverage. FY2025 net sales were $6.0B (-2.5%), adjusted EBITDA rose to $408.2M (+21.3%), and net income was $9.1M versus a prior-year loss.
Cash increased to $256.7M after $95M voluntary debt paydown; the company completed debt refinancing to extend maturities to 2031 and provided FY2026 guidance of adjusted EBITDA $415M–$430M with net sales flat to +1.5%.
Positive
- Adjusted EBITDA +21.3% to $408.2M in FY2025
- Net income of $9.1M versus a $101.8M loss prior year
- Leverage ratio improved from 4.2X to 3.0X by year-end 2025
- Cash balance +$91.0M to $256.7M after debt paydown
- Completed debt refinancing extending maturities to 2031
Negative
- Net sales declined 2.5% to $6.0B in FY2025
- Comparable sales decreased 1.6% year over year
- Q4 net sales down 2.4% to $1.5B
- Guidance expects net store closures of ~15–20 in 2026
- Q1 2026 sales guidance: down 1% to flat year over year
Market Reaction – WOOF
Following this news, WOOF has gained 5.42%, reflecting a notable positive market reaction. Argus tracked a peak move of +12.9% during the session. Our momentum scanner has triggered 18 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $2.53. This price movement has added approximately $39M to the company's valuation.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.
Key Figures
Market Reality Check
Peers on Argus
Scanner data flags WOOF moving up with elevated volume while only one peer, BBW, also screens higher (~2.82%). Other specialty retail peers show smaller moves, suggesting this earnings release is driving a stock-specific reaction rather than a broad sector shift.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 25 | Q3 2025 earnings | Positive | +14.5% | Q3 2025 results with margin expansion and raised fiscal 2025 earnings outlook. |
| Aug 28 | Q2 2025 earnings | Positive | +23.5% | Q2 2025 profitability gains, margin expansion, and higher adjusted EBITDA guidance. |
| Jun 05 | Q1 2025 earnings | Positive | -23.3% | Q1 2025 sales decline but better margins and improved operating income and EBITDA. |
| Mar 26 | FY 2024 earnings | Positive | +31.6% | Q4 and FY 2024 results with smaller GAAP loss and cash flow metrics disclosed. |
| Dec 05 | Q3 2024 earnings | Positive | +8.0% | Q3 2024 revenue growth, improved gross profit, and higher adjusted EBITDA. |
Earnings releases have often been followed by strong moves, mostly positive when profitability and guidance improved, with one notable divergence where shares fell despite better margins.
Over the last five earnings updates from Dec 2024 through Nov 2025, Petco repeatedly reported modest revenue pressure but steady margin expansion and improving profitability. The company raised or reaffirmed earnings guidance multiple times and highlighted adjusted EBITDA growth and cost discipline. Share price reactions were frequently strong, with several double-digit gains following earnings reports. Today’s fourth quarter and full year 2025 results continue themes of higher margins, improved adjusted EBITDA, and a focus on leverage and cash generation versus top-line growth.
Historical Comparison
Across the last 5 earnings releases, WOOF saw an average move of about 10.84%, with most reports highlighting margin expansion and improving adjusted EBITDA.
Earnings updates from late 2024 through 2025 show a progression from sizable GAAP losses toward improved profitability, with recurring themes of gross margin expansion, rising adjusted EBITDA, tighter cost control, and more detailed full-year guidance framing the company’s turnaround narrative.
Market Pulse Summary
The stock is up +5.4% following this news. A strong positive reaction aligns with Petco’s pattern of sizable moves around earnings, where prior reports often paired modest sales pressure with clear profitability gains. This release highlighted higher gross margins, rising Adjusted EBITDA, improved net income, and stronger free cash flow alongside lower secured debt. Elevated short-term enthusiasm could face risks from the flat-to-low growth 2026 sales outlook and the need to sustain margin improvements over time.
Key Terms
adjusted ebitda financial
free cash flow financial
leverage ratio financial
capital expenditures financial
depreciation & amortization financial
non-gaap financial measures financial
basis points financial
net interest expense financial
AI-generated analysis. Not financial advice.
Delivers Profitability Ahead of Outlook, Reduces Leverage Ratio
Provides Fiscal 2026 Outlook*
"In fiscal 2025, we strengthened our leadership team and rebuilt the foundation of our economic model, enabling us to exceed our profitability goals," said Joel Anderson, Chief Executive Officer of Petco. "With that work largely complete, we are entering the next phase of our strategy focused on driving sustainable, profitable top‑line growth."
Anderson continued, "As we look ahead, we see significant opportunities across core consumables, supplies and services. We are confident that our focus on driving product newness and innovation as well as leveraging our differentiated, high touch store ecosystem will help us to grow market share. Our outlook reflects our strategic initiatives and assumes a return to positive comps in 2026."
Q4 2025 Overview
For the fourth quarter of 2025 compared to the fourth quarter of 2024:
- Net sales of
decreased$1.5 billion 2.4% ; comparable sales decreased1.6% . - Gross profit decreased
1.4% to and gross margin increased 37 basis points to$580.8 million 38.3% . - Operating income increased
83.2% to ; operating margin increased 98 basis points to$31.9 million 2.1% . - Net loss of
versus a loss of$2.6 million .$13.8 million - Adjusted EBITDA1 increased
10.6% to , well above the Company's outlook.$106.3 million - The Company closed 7 net stores, ending the year with 1,382 stores.
Full Year 2025 Overview
For the full year 2025 compared to the full year of 2024:
- Net sales of
decreased$6.0 billion 2.5% ; comparable sales decreased1.6% . - Gross profit decreased
0.8% to and gross margin increased 66 basis points to$2.3 billion 38.7% . - Operating income increased to
from$120.4 million ; operating margin increased 190 basis points to$7.1 million 2.0% . - Net income of
, up from a loss of$9.1 million .$101.8 million - Adjusted EBITDA1 increased
21.3% to , above the Company's outlook.$408.2 million
Sabrina Simmons, Chief Financial Officer of Petco, added, "Petco once again delivered on our commitments while building a stronger foundation, improving profitability and cash generation through our economic model. These results enabled significant progress in achieving our goal of lowering our leverage ratio1 from 4.2X when we entered the year to 3X at the end of 2025. As we enter this next phase of growth, we see ongoing opportunity to improve our financial strength."
Full Year 2025 Balance Sheet and Cash Flow
- Cash grew by
to$91.0 million after voluntarily paying down$256.7 million in debt.$95.0 million - Inventory fell
9.7% versus the2.5% decline in sales. - Cash from operations rose by
or$136.4 million 76.8% to .$314.1 million - Free cash flow1 was
, an increase of$187.0 million or$137.3 million 276.3% above last year. - Total secured debt was
~ , down from$1.5 billion last year.$1.59 5 billion - The Company completed the refinancing of its debt on February 2, extending its maturities to 2031 and providing ample flexibility through a mix of fixed and floating rate instruments consisting of a
variable rate term loan and$900 million fixed rate bond.$600 million
2026 Guidance
For fiscal 2026 and Q1, the Company is providing guidance as follows.
Full Year 2026 Outlook
FY 2026 Outlook* | |
Net Sales | Flat to up |
Adjusted EBITDA1 | |
Net Interest Expense | |
Capital Expenditures | |
Depreciation & Amortization | |
Net Store Closures | ~15-20 |
First Quarter 2026 Outlook
Q1 2026 Outlook* | |
Net Sales | Down |
Adjusted EBITDA1 |
*Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the
(1) | Adjusted EBITDA, Free Cash Flow, and Leverage Ratio are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures. |
Earnings Conference Call Webcast Information:
Management will host an earnings conference call on March 11, 2026 at approximately 4:30 PM Eastern Time to discuss the company's financial results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after the conference call.
About Petco:
We're proud to be "where the pets go" to find everything they need to live their best lives for more than 60 years — from their favorite meals and toys, to trusted supplies and expert support from people who get it, because we live it. We believe in the universal truths of pet parenthood — the boundless boops, missing slippers, late night zoomies and everything in between. And we're here for it. Every tail wag, every vet visit, every step of the way. We nurture the pet-human bond in the aisles of more than 1,500 Petco stores across the
Forward-Looking Statements:
This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our Q1 and full year 2026 outlook, operational reset of our business, our competitive positioning, profitability, cash generation through our economic model, expense leverage, operating margin expansion, cost action plans and associated cost-savings, our path to sustainable, profitable growth and our expectations regarding tariffs and associated impacts. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. These statements are only predictions based on our current expectations and projections about future events and reflect our beliefs regarding such future events and do not represent historical facts or statements of current condition. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation, prevailing interest rates and the impact of tariffs; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflicts in
Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.
PETCO HEALTH AND WELLNESS COMPANY, INC. | |||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||
(In thousands, except per share amounts) | |||||||||
(Unaudited and subject to reclassification) | |||||||||
13 Weeks Ended | 52 Weeks Ended | ||||||||
January 31, | February 1, | January 31, | February 1, | ||||||
Net sales: | |||||||||
Products | $ 1,259,226 | $ 1,310,217 | $ 4,936,323 | $ 5,116,891 | |||||
Services and other | 255,902 | 241,913 | 1,025,144 | 999,571 | |||||
Total net sales | 1,515,128 | 1,552,130 | 5,961,467 | 6,116,462 | |||||
Cost of sales: | |||||||||
Products | 775,588 | 811,204 | 3,028,909 | 3,173,269 | |||||
Services and other | 158,770 | 151,666 | 627,486 | 618,791 | |||||
Total cost of sales | 934,358 | 962,870 | 3,656,395 | 3,792,060 | |||||
Gross profit | 580,770 | 589,260 | 2,305,072 | 2,324,402 | |||||
Selling, general and administrative expenses | 548,914 | 571,872 | 2,184,639 | 2,317,351 | |||||
Operating income | 31,856 | 17,388 | 120,433 | 7,051 | |||||
Interest income | (2,223) | (1,278) | (6,305) | (3,714) | |||||
Interest expense | 31,581 | 34,111 | 131,199 | 143,531 | |||||
Loss on extinguishment and modification of debt | 565 | — | 565 | — | |||||
Other non-operating loss (income) | — | 1,000 | — | (4,800) | |||||
Income (loss) before income taxes and income from | 1,933 | (16,445) | (5,026) | (127,966) | |||||
Income tax expense (benefit) | 11,301 | 2,504 | 6,266 | (7,481) | |||||
Income from equity method investees | (6,793) | (5,112) | (20,358) | (18,669) | |||||
Net (loss) income attributable to Class A and B-1 common | $ (2,575) | $ (13,837) | $ 9,066 | $ (101,816) | |||||
Net (loss) income per Class A and B-1 common share: | |||||||||
Basic | $ (0.01) | $ (0.05) | $ 0.03 | $ (0.37) | |||||
Diluted | $ (0.01) | $ (0.05) | $ 0.03 | $ (0.37) | |||||
Weighted average shares used in computing net (loss) income per Class A | |||||||||
Basic | 281,236 | 276,305 | 279,555 | 273,410 | |||||
Diluted | 281,236 | 276,305 | 286,148 | 273,410 | |||||
PETCO HEALTH AND WELLNESS COMPANY, INC. | ||||
CONSOLIDATED BALANCE SHEETS | ||||
(In thousands, except per share amounts) | ||||
(Unaudited and subject to reclassification) | ||||
January 31, | February 1, | |||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ 256,736 | $ 165,756 | ||
Receivables, less allowance for credit losses1 | 45,812 | 40,425 | ||
Merchandise inventories, net | 590,210 | 653,329 | ||
Prepaid expenses | 51,747 | 53,515 | ||
Other current assets | 75,281 | 60,594 | ||
Total current assets | 1,019,786 | 973,619 | ||
Fixed assets, net | 656,148 | 725,438 | ||
Operating lease right-of-use assets | 1,288,593 | 1,302,346 | ||
Goodwill | 980,064 | 980,064 | ||
Trade name | 1,025,000 | 1,025,000 | ||
Other long-term assets | 203,834 | 187,963 | ||
Total assets | $ 5,173,425 | $ 5,194,430 | ||
LIABILITIES AND EQUITY | ||||
Current liabilities: | ||||
Accounts payable and book overdrafts | $ 450,552 | $ 492,878 | ||
Accrued salaries and employee benefits | 154,148 | 157,460 | ||
Accrued expenses and other liabilities | 204,751 | 177,079 | ||
Current portion of operating lease liabilities | 320,082 | 306,400 | ||
Current portion of long-term debt and other lease liabilities | 4,608 | 5,346 | ||
Total current liabilities | 1,134,141 | 1,139,163 | ||
Senior secured credit facilities, net, excluding current portion | 1,488,527 | 1,578,091 | ||
Operating lease liabilities, excluding current portion | 1,047,185 | 1,037,206 | ||
Deferred taxes, net | 234,911 | 217,712 | ||
Other long-term liabilities | 104,407 | 108,628 | ||
Total liabilities | 4,009,171 | 4,080,800 | ||
Commitments and contingencies | ||||
Stockholders' equity: | ||||
Class A common stock2 | 244 | 239 | ||
Class B-1 common stock3 | 38 | 38 | ||
Class B-2 common stock4 | — | — | ||
Preferred stock5 | — | — | ||
Additional paid-in-capital | 2,312,354 | 2,280,495 | ||
Accumulated deficit | (1,139,993) | (1,149,059) | ||
Accumulated other comprehensive loss | (8,389) | (18,083) | ||
Total stockholders' equity | 1,164,254 | 1,113,630 | ||
Total liabilities and stockholders' equity | $ 5,173,425 | $ 5,194,430 | ||
1 Allowances for credit losses are | ||||
2 Class A common stock, | ||||
3 Class B-1 common stock, | ||||
4 Class B-2 common stock, | ||||
5 Preferred stock, |
PETCO HEALTH AND WELLNESS COMPANY, INC. | ||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(In thousands) | ||||
(Unaudited and subject to reclassification) | ||||
52 Weeks Ended | ||||
January 31, | February 1, | |||
Cash flows from operating activities: | ||||
Net income (loss) | $ 9,066 | $ (101,816) | ||
Adjustments to reconcile net income (loss) to net cash provided by | ||||
Depreciation and amortization | 196,710 | 208,517 | ||
Amortization of debt discounts and issuance costs | 5,022 | 4,896 | ||
Provision for deferred taxes | 17,050 | (30,492) | ||
Equity-based compensation expense | 32,650 | 50,212 | ||
Loss on extinguishment and modification of debt | 565 | — | ||
Income from equity method investees | (20,358) | (18,669) | ||
Amounts reclassified out of accumulated other comprehensive loss | (556) | (3,146) | ||
Non-cash operating lease costs | 411,812 | 414,396 | ||
Other non-operating income | — | (4,800) | ||
Changes in assets and liabilities: | ||||
Receivables | (5,621) | 4,178 | ||
Merchandise inventories | 63,119 | 30,767 | ||
Prepaid expenses and other assets | 818 | (3,960) | ||
Accounts payable and book overdrafts | (42,992) | 8,484 | ||
Accrued salaries and employee benefits | (3,271) | 56,981 | ||
Accrued expenses and other liabilities | 24,987 | (12,455) | ||
Operating lease liabilities | (371,134) | (418,219) | ||
Other long-term liabilities | (3,817) | (7,201) | ||
Net cash provided by operating activities | 314,050 | 177,673 | ||
Cash flows from investing activities: | ||||
Cash paid for fixed assets | (127,097) | (127,990) | ||
Cash paid for acquisitions, net of cash acquired | — | (629) | ||
Cash paid for investments | — | (457) | ||
Proceeds from investment | — | 998 | ||
Proceeds from sale of assets | 2,541 | 1,369 | ||
Cash received from partial surrender of officers' life insurance | — | 2,806 | ||
Net cash used in investing activities | (124,556) | (123,903) | ||
Cash flows from financing activities: | ||||
Borrowings under long-term debt agreements | — | 201,000 | ||
Repayments of long-term debt | (95,250) | (201,000) | ||
Debt refinancing costs | — | (3,028) | ||
Payments for finance lease liabilities | (5,614) | (5,707) | ||
Proceeds from employee stock purchase plan and stock option exercises | 3,677 | 3,770 | ||
Tax withholdings on stock-based awards | (4,560) | (6,289) | ||
Proceeds from issuance of common stock | — | 2,500 | ||
Net cash used in financing activities | (101,747) | (8,754) | ||
Net decrease in cash, cash equivalents and restricted cash | 87,747 | 45,016 | ||
Cash, cash equivalents and restricted cash at beginning of period | 181,665 | 136,649 | ||
Cash, cash equivalents and restricted cash at end of period | $ 269,412 | $ 181,665 | ||
NON-GAAP FINANCIAL MEASURES
The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.
Adjusted EBITDA
Adjusted EBITDA is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended February 1, 2025 filed with the SEC on March 31, 2025 for additional information on Adjusted EBITDA.
The table below reflects the calculation of Adjusted EBITDA for the thirteen and fifty-two weeks ended January 31, 2026 compared to the thirteen and fifty-two weeks ended February 1, 2025.
(dollars in thousands) | 13 Weeks Ended | 52 Weeks Ended | ||||||
Reconciliation of Net (Loss) Income Attributable to Class A and B-1 | January 31, | February 1, | January 31, | February 1, | ||||
Net (loss) income attributable to Class A and B-1 common stockholders | $ (2,575) | $ (13,837) | $ 9,066 | $ (101,816) | ||||
Add (deduct): | ||||||||
Interest expense, net | 29,358 | 32,833 | 124,894 | 139,817 | ||||
Income tax expense (benefit) | 11,301 | 2,504 | 6,266 | (7,481) | ||||
Depreciation and amortization | 47,567 | 50,654 | 196,710 | 208,517 | ||||
Income from equity method investees | (6,793) | (5,112) | (20,358) | (18,669) | ||||
Loss on debt extinguishment and modification | 565 | — | 565 | — | ||||
Equity-based compensation expense | 7,278 | 9,507 | 32,650 | 50,212 | ||||
Other non-operating loss (income) | — | 1,000 | — | (4,800) | ||||
13,915 | 11,233 | 46,135 | 41,615 | |||||
Acquisition and divestiture-related integration costs (2) | — | — | — | 3,719 | ||||
Other costs (3) | 5,678 | 7,341 | 12,239 | 25,412 | ||||
Adjusted EBITDA | $ 106,294 | $ 96,123 | $ 408,167 | $ 336,526 | ||||
Net sales | $ 1,515,128 | $ 1,552,130 | $ 5,961,467 | $ 6,116,462 | ||||
Net margin (4) | (0.2 %) | (0.9 %) | 0.2 % | (1.7 %) | ||||
Adjusted EBITDA Margin | 7.0 % | 6.2 % | 6.8 % | 5.5 % | ||||
(1) |
13 Weeks Ended | 52 Weeks Ended | |||||||
(in thousands) | January 31, | February 1, | January 31, | February 1, | ||||
Net income | $ 13,586 | $ 10,224 | $ 40,715 | $ 37,559 | ||||
Depreciation | 7,819 | 6,536 | 28,934 | 27,360 | ||||
Income tax expense | 5,668 | 5,014 | 18,267 | 16,010 | ||||
Foreign currency (gain) loss | (225) | 176 | 772 | 169 | ||||
Interest expense, net | 982 | 516 | 3,581 | 2,131 | ||||
EBITDA | $ 27,830 | $ 22,466 | $ 92,269 | $ 83,229 | ||||
$ 13,915 | $ 11,233 | $ 46,135 | $ 41,615 | |||||
(2) | Acquisition and divestiture-related integration costs include direct costs resulting from acquiring, integrating, or divesting businesses. These include third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs that would not have otherwise been incurred as part of the company's operations. |
(3) | Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions. In fiscal 2025, other costs were primarily driven by |
(4) | We define net margin as net loss attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales. |
Free Cash Flow
Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.
The table below reflects the calculation of Free Cash Flow for the thirteen and fifty-two weeks ended January 31, 2026 compared to the thirteen and fifty-two weeks ended February 1, 2025.
(in thousands) | 13 Weeks Ended | 52 Weeks Ended | ||||||
January 31, | February 1, | January 31, | February 1, | |||||
Net cash provided by operating activities | $ 153,522 | $ 95,993 | $ 314,050 | $ 177,673 | ||||
Cash paid for fixed assets | (37,137) | (36,949) | (127,097) | (127,990) | ||||
Free Cash Flow | $ 116,385 | $ 59,044 | $ 186,953 | $ 49,683 | ||||
Leverage
Leverage
The table below reflects the calculation for Leverage Ratio for the fifty-two weeks ended January 31, 2026 compared to the fifty-two weeks ended February 1, 2025.
(dollars in thousands) | January 31, | February 1, | ||
Total debt: | ||||
Senior secured credit facilities, net, including current portion | $ 1,488,527 | $ 1,578,091 | ||
Finance leases, including current portion | 9,683 | 13,793 | ||
Total debt | 1,498,210 | 1,591,884 | ||
Less: cash and cash equivalents | (256,736) | (165,756) | ||
Net Debt | $ 1,241,474 | $ 1,426,128 | ||
Adjusted EBITDA | $ 408,167 | $ 336,526 | ||
Net Debt / Adjusted EBITDA ratio | 3.0x | 4.2x |
View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-reports-fourth-quarter-and-full-year-2025-results-302711280.html
SOURCE Petco - Investor Relations
FAQ
What were Petco (WOOF) full-year 2025 net sales and growth?
How much did Petco (WOOF) improve adjusted EBITDA in FY2025?
What debt and liquidity changes did Petco (WOOF) report on March 11, 2026?
What is Petco's (WOOF) full-year 2026 guidance for sales and adjusted EBITDA?
What does Petco's (WOOF) short-term outlook say about Q1 2026 performance?